Follow-on offering Announced
Silexion Therapeutics Corp equity raising
US$2.5m raised
NASDAQ: SLXN · US$0.65 cash per share
Advisers
Lead managers
- Legal adviser
- Placement agent
- Issuer
- Silexion Therapeutics Corp
- Issuer based in
- Israel
- Sector
- Biotech
- Tags
- Biotech, Oncology, Drug Development
Similar deals
- Remix Therapeutics placement Jun 2026 · US$100m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
Sources
- 13 Aug 2026 Final IPO prospectus (424B4), Silexion Therapeutics Corp sec.gov

